Fotivda 1.34 MG capsule 21S
Ended Awarded Last action
- Contract number
- SPE2DR26F9MA0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $40,377
Award facts
- Contract value 100% obligated
- $40,376.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $40,376.56 firm fixed-price delivery order to Amerisourcebergen Drug Corp on January 20, 2026, for the supply of FOTIVDA 1.34 milligram capsules (21 count). This non-competitive delivery order will be performed in Conshohocken, Pennsylvania, with an ultimate completion date of February 10, 2026. The award represents a task order against Amerisourcebergen's parent company, Cencora, Inc. (doing business as Amerisourcebergen), which holds a substantial Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999 through December 31, 2031. This prime contract vehicle provides comprehensive pharmaceutical and medical supply support to military healthcare programs globally across multiple therapeutic domains.
FOTIVDA (tivozanib) is an oral tyrosine kinase inhibitor used in the treatment of renal cell carcinoma, reflecting the Defense Logistics Agency's role in supplying specialized oncology medications to military treatment facilities and veteran healthcare programs. As a major pharmaceutical distributor, Cencora/Amerisourcebergen demonstrates significant capability in fulfilling federal medical procurement requirements through competitive and non-set-aside contract mechanisms. The delivery order structure allows for efficient fulfillment of specific medication needs within the larger framework of the agency's global pharmaceutical supply chain supporting Department of Defense and veteran medical operations.
Quick answers
Who was awarded contract SPE2DR26F9MA0?
SPE2DR26F9MA0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26F9MA0 worth?
The government has obligated $40,377 on SPE2DR26F9MA0.
Is contract SPE2DR26F9MA0 an order under another contract?
Yes. SPE2DR26F9MA0 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9MA0 competed?
The extent of competition for SPE2DR26F9MA0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award